Skip to Content

Elosulfase Alfa

In the US, Elosulfase Alfa (elosulfase alfa systemic) is a member of the drug class lysosomal enzymes and is used to treat Mucopolysaccharidosis Type IV.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A16AB12

CAS registry number (Chemical Abstracts Service)

0009025-60-9

Chemical Formula

C5020-H7574-N1364-O1418-S34

Molecular Weight

110810

Therapeutic Category

Enzyme

Chemical Name

human N-acetylgalactosamine-6-sulfatase (chondroitinsulfatase, galactose-6-sulfate sulfatase, EC=3.1.6.4) dimer (139-139')-disulfide glycosylated (produced by CHO cells) (WHO )

Foreign Names

  • Elosulfasum alfa (Latin)
  • Elosulfase alfa (German)
  • Elosulfase alfa (French)
  • Elosulfasa alfa (Spanish)

Generic Names

Brand Names

  • Vimizim
    BioMarin, Germany; BioMarin, Denmark; BioMarin, Netherlands; BioMarin, United States; BioMarin Europe, France; BioMarin Europe, Sweden; DRAC, Switzerland

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide